Stay updated on Belantamab Combo in Newly Diagnosed Myeloma Clinical Trial
Sign up to get notified when there's something new on the Belantamab Combo in Newly Diagnosed Myeloma Clinical Trial page.

Latest updates to the Belantamab Combo in Newly Diagnosed Myeloma Clinical Trial page
- Check3 days agoChange DetectedThe history now shows a new Revision: v3.5.2 and removes the prior Revision: v3.5.0.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedSponsor information (Hellenic Society of Hematology), verification status, and last known status (Recruiting) were added for the 2023-11 update. The record history revision was updated from v3.4.3 to v3.5.0.SummaryDifference0.9%

- Check39 days agoChange DetectedA new revision, v3.4.3, has been added to the study record history and the previous revision v3.4.2 has been removed.SummaryDifference0.1%

- Check68 days agoChange DetectedA new revision entry (v3.4.2) was added to the study history. The funding-lapse notice and the previous revision entry (v3.4.1) were removed.SummaryDifference0.9%

- Check75 days agoChange DetectedNotice about government funding and open status was added, along with a new revision tag (v3.4.1), replacing the previous revision (v3.4.0).SummaryDifference0.9%

- Check82 days agoChange DetectedThe history page now includes a 'Show glossary' option and color-coding explanations (green for additions, red for deletions). The revision notes updated to v3.4.0 with No FEAR Act data labeling, and the older v3.3.4 entry was removed.SummaryDifference1%

Stay in the know with updates to Belantamab Combo in Newly Diagnosed Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belantamab Combo in Newly Diagnosed Myeloma Clinical Trial page.